Tested Applications
| Positive WB detected in | Calyculin A treated HEK-293 cells |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:2000-1:16000 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
29199-1-AP targets Phospho-MKK7 (Ser271/Thr275) in WB, ELISA applications and shows reactivity with Human samples.
| Tested Reactivity | Human |
| Cited Reactivity | human |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
Peptide Predict reactive species |
| Full Name | mitogen-activated protein kinase kinase 7 |
| Calculated Molecular Weight | 47 kDa |
| Observed Molecular Weight | 47-52 kDa |
| GenBank Accession Number | BC038295 |
| Gene Symbol | MKK7 |
| Gene ID (NCBI) | 5609 |
| RRID | AB_2918246 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | O14733 |
| Storage Buffer | PBS with 0.02% sodium azide, 50% glycerol, and 0.05% BSA, pH 7.3. |
| Storage Conditions | Store at -20°C. Aliquoting is unnecessary for -20oC storage. |
Background Information
Dual specificity mitogen-activated protein kinase kinase 7 (MKK7), also known as MEK7 or MAP2K7, is a member of mitogen-activated kinase kinase (MAP2K) subfamily, and a key activator of c-Jun N-terminal kinase (JNK) signaling, a pathway that regulates primarily stress and inflammatory responses. MKK7 activity can be increased by either MKK7-autophosphorylation or phosphorylation of the Ser and Thr residues of the S-X-A-K-T motifs in the Kinase domain by upstream MEKK1, MEKK2, or MLK3.(PMID: 32783966, PMID: 31579105)
Protocols
| Product Specific Protocols | |
|---|---|
| WB protocol for Phospho-MKK7 (Ser271/Thr275) antibody 29199-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The Phospho-MKK7 (Ser271/Thr275) Polyclonal antibody (Cat# 29199-1-AP) has 2 citations. One appears in Cell Reports in Medicine, studying FBXO3-mediated DUSP9 ubiquitination in leukemia stem cell maintenance and tyrosine kinase inhibitor resistance in chronic myeloid leukemia. The other is in Journal of Ethnopharmacology, investigating Xinlikang capsule's effects on cancer-related fatigue, oxidative stress, JNK activation, and bone marrow apoptosis in tumor-bearing mice. Research fields span oncology, hematological malignancies, and traditional medicine.
| Species | Application | Title |
|---|---|---|
Cell Rep Med FBXO3-mediated DUSP9 ubiquitination promotes leukemia stem cell maintenance and tyrosine kinase inhibitor resistance in chronic myeloid leukemia. | ||
J Ethnopharmacol Xinlikang capsule ameliorates cancer-related fatigue in Lewis lung carcinoma tumor-bearing mice: association with inhibition of oxidative stress and attenuation of JNK activation and bone marrow apoptosis. |

